beta

ADRO

Aduro Biotech Inc.

Adro

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Aduro Biotech Inc is a clinical-stage biotechnology company focused on the discovery, development and commercialization of therapies that transform the treatment of different diseases.

Market Cap: 522 Million

Primary Exchange: Nasdaq Global Select

Website: http://www.aduro.com

Shares Outstanding: 77.3 Million

Float: 76.2 Million

Dividend: 0.0 (0.0%)

Beta: 2.994359

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 6.57 Million

Ethical Flags

Animal testing

Longest drawdown: 1643 trading days

From: 2015-04-20 To: 2019-10-11

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud